Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

First launch for Lipobay

April 22, 1997

ACAT inhibitors from Nihon Nohyaku

April 22, 1997

Cholesterol biosynthesis inhibitors described by Nippon Soda

April 21, 1997

Teijin and Microbial Chemistry Research Foundation reveal acetyl-CoA carboxylase inhibitor

April 21, 1997

Novavax completes phase Ia trial of generic human testosterone drug

April 21, 1997

Antidiabetic coumarin derivatives from Otsuka

April 21, 1997

Alteon reports positive results from phase II trials with pimagedine

April 18, 1997

Atorvastatin available in Germany for hyperlipidemia

April 18, 1997

Positive phase I data reported for liposomal PGE1 product for erectile dysfunction

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...